Company profile

Ticker
VXRT
Exchange
CEO
Wouter W. Latour
Employees
Incorporated in
Location
Fiscal year end
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., Nabi Biopharmaceuticals, Nabi, Nabi Biopharmaceuticals, North American Biologicals Inc
SEC CIK
IRS number
591212264

VXRT stock data

(
)

Calendar

8 Aug 19
21 Oct 19
31 Dec 19

News

Company financial data Financial data

Quarter (USD) Jun 19 Mar 19 Dec 18 Sep 18
Revenue 85K 5.41M 1.77M 281K
Net income -5.64M -1.34M -4.9M -6.55M
Diluted EPS -0.39 -0.18 -0.69 -0.92
Net profit margin -6632% -24.76% -277% -2330%
Operating income -5M -448K -4.19M -5.88M
Net change in cash 7.88M -3.08M -6.48M -6M
Cash on hand 16.24M 8.36M 11.44M 17.92M
Cost of revenue
Annual (USD) Dec 18 Dec 17
Revenue 4.16M 5.84M
Net income -18.01M -9.58M
Diluted EPS -2.9 -91.65
Net profit margin -433% -164%
Operating income -21.76M -10.02M
Net change in cash 9.87M
Cash on hand 11.44M 1.57M
Cost of revenue

Financial data from Vaxart earnings reports

Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Avg
New words: accredited, bid, consecutive, conventional, delisted, delisting, deprioritized, encompassing, Fundamental, grace, Janssen, mortgage, notice, notification, Panel, penny, permanent, regain, residence, secondary, spouse, topline, underway, unexercised, worth
Removed: live, projected, reserve, scheduled